Gene · 2230
Papers1,417
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,417
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LRPPRC-Driven Oxidative Phosphorylation Is Associated with Elesclomol-Induced Cuproptosis in Ovarian Cancer. | Int J Mol Sci | 2025 | 41516324 | PubTator, text mining | PubMed |
| [Mechanism of ginsenoside Rb_1 in ameliorating hypoxia/reoxygenation injury in H9c2 cardiomyocytes through CTR1 ubiquitination-mediated regulation of cuproptosis]. | Zhongguo Zhong Yao Za Zhi | 2025 | 41507748 | PubTator, text mining | PubMed |
| Ferroptosis: Mechanisms, Comparison with Cuproptosis and Emerging Horizons in Therapeutics. | Oncol Res | 2025 | 41502519 | PubTator, text mining | PubMed |
| Copper-Induced Cell Death in Renal Diseases: Molecular Mechanisms and Therapeutic Implications. | Drug Des Devel Ther | 2025 | 41497347 | PubTator, text mining | PubMed |
| Atractylenolide III mitigates polycystic ovary syndrome by activating FDX1-mediated proliferation of ovarian granulocyte cells via PI3K/AKT/mTOR. | J Ovarian Res | 2025 | 41469708 | PubTator, text mining | PubMed |
| Deep Mutational Scanning of FDX1 Identifies Key Structural Determinants of Lipoylation and Cuproptosis. | Nat Commun | 2025 | 41423452 | PubTator, text mining | PubMed |
| METTL3 Represses FDX1 Expression Through m6A Methylation to Facilitate the Malignant Progression of Breast Cancer. | J Biochem Mol Toxicol | 2025 | 41355519 | PubTator, text mining | PubMed |
| The synergistic pathogenic mechanism of Brucella melitensis M5-90 effector protein BspC in regulating host cell apoptosis, inflammation and oxidative stress. | J Med Microbiol | 2025 | 41348573 | PubTator, text mining | PubMed |
| Targeting multiple genetic defects of mitochondrial diseases with a single bacterial lipoate protein ligase. | Sci Adv | 2025 | 41337580 | PubTator, text mining | PubMed |
| lncRNA RP11-199F11.2 promotes high-grade serous ovarian cancer cell proliferation by regulating cuproptosis through FDX1. | Sci Rep | 2025 | 41286314 | PubTator, text mining | PubMed |
| Corin: a dual inhibitor for KDM1A/HDAC1, suppresses hepatocellular carcinoma by triggering cuproptosis. | Clin Exp Med | 2025 | 41286164 | PubTator, text mining | PubMed |
| Targeting SERPINB3-MAPK axis-mediated cuproptosis resistance enhances the response to antitumor immunotherapy. | Mol Cancer | 2025 | 41275193 | PubTator, text mining | PubMed |
| Aged microplastics disrupted copper homeostasis to induce vascular toxicity: in vivo and human vascular organoids-based in vitro study. | Environ Int | 2025 | 41270660 | PubTator, text mining | PubMed |
| Ferredoxins: master regulators in mitochondrial redox homeostasis and programmed cell death. | Redox Biol | 2025 | 41260099 | PubTator, text mining | PubMed |
| Cu-doped dendritic biodegradable nanoplatforms for augmenting cuproptosis and tumor-starvation therapy through mitochondrial metabolic cascade modulation. | Mater Today Bio | 2025 | 41255424 | PubTator, text mining | PubMed |
Targeted inhibition of gastric adenocarcinoma by nano-curcumin liposomes: Insights from combined machine learning and experimental analyses into the mechanisms of cuproptosis and metabolic reprogramming. | Int J Pharm | 2025 | 41218732 | PubTator, text mining | PubMed |
| Unraveling the miR-144-3p/PUMA pathway: a novel regulator of FDX1-mediated cuproptosis in colorectal cancer. | Cell Oncol (Dordr) | 2025 | 41212484 | PubTator, text mining | PubMed |
| Identification and validation of cuproptosis-related immune checkpoint expression for glioblastoma. | BMC Cancer | 2025 | 41199254 | PubTator, text mining | PubMed |
| Cuproptosis in stroke: Molecular mechanisms and therapeutic targeting of copper-mediated cell death. | Brain Res Bull | 2025 | 41183713 | PubTator, text mining | PubMed |
| Iron, copper and disulfide dysregulation: molecular crossroads of metabolic cell death in melanoma progression. | Front Pharmacol | 2025 | 41170386 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2230/papers?page=8